share_log

白云山:子公司药品通过仿制药一致性评价

BAIYUNSHAN PH: Subsidiary Pharmaceutical passed the consistency evaluation for generic drugs.

Breakings ·  Mar 28 10:19

BAIYUNSHAN PH announced that its holding subsidiary Tianxin Pharmaceutical's injectable ampicillin sodium (1.0g, 0.5g) has passed the consistency evaluation for quality and efficacy of generic drugs. In 2024, the sales volume of this Pharmaceutical in the domestic market is 692.01 million yuan, with Tianxin Pharmaceutical's sales revenue at 1.1507 million yuan. As of the announcement date, Tianxin Pharmaceutical has invested approximately 1.8284 million yuan in R&D expenses for this project.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 385

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.